Reduction of leukemic burden via bone‐targeted nanoparticle delivery of an inhibitor of C‐chemokine (C‐C motif) ligand 3 (CCL3) signaling

Ackun‐Farmmer, M. A., Soto, C. A., Lesch, M. L., Byun, D., Yang, L., Calvi, L. M., Benoit, D. S. W. and Frisch, B. J.  Reduction of leukemic burden via bone‐targeted nanoparticle delivery of an inhibitor of C‐chemokine (C‐C motif) ligand 3 (CCL3) signaling.  The FASEB Journal. 2021; 35(4).  doi: 10.1096/fj.202000938rr